Thyroid hormone-mediated activation of the ERK/dual specificity phosphatase 1 pathway augments the apoptosis of GH4C1 cells by down-regulating nuclear factor-κB activity

Molecular Endocrinology

Volumn 22, Issue 11, 2008, Pages 2466-2480

  Chiloeches, Antonio ^a   Sánchez Pacheco, Aurora ^b   Gil Araujo, Beatriz ^b   Aranda, Ana ^b   Lasa, Marina ^b  

^a UNIVERSITY OF ALCALÁ   (Spain)

^b INSTITUTO DE INVESTIGACIONES BIOMÉDICAS ALBERTO SOLS   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

DUAL SPECIFITY PHOSPHATASE 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; PHOSPHATASE; STRESS ACTIVATED PROTEIN KINASE; SYNAPTOTAGMIN I; THYROID HORMONE; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT;

ANIMALS; APOPTOSIS; BASE SEQUENCE; CELL LINE; CULTURE MEDIA, SERUM-FREE; DNA PRIMERS; DOWN-REGULATION; DUAL SPECIFICITY PHOSPHATASE 1; GENES, BCL-2; INHIBITOR OF APOPTOSIS PROTEINS; MITOGEN-ACTIVATED PROTEIN KINASES; NF-KAPPA B; PITUITARY GLAND; RATS; TRIIODOTHYRONINE;

RATTUS;

EID: 55049122438     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/me.2008-0107     Document Type: Article

References (71)

1. Aranda A, Pascual A 2001 Nuclear hormone receptors and gene expression. Physiol Rev 81:1269-1304
2. Fernandez M, Sanchez-Franco F, Palacios N, Sanchez I, Fernandez C, Cacicedo L 2004 IGF-I inhibits apoptosis through the activation of the phosphatidylinositol 3-kinase/ Akt pathway in pituitary cells. J Mol Endocrinol 33:155-163
3. Tashjian Jr AH 1979 Clonal strains of hormone-producing pituitary cells. Methods Enzymol 58:527-535
4. Tang HY, Lin HY, Zhang S, Davis FB, Davis PJ 2004 Thyroid hormone causes mitogen-activated protein kinase-dependent phosphorylation of the nuclear estrogen receptor. Endocrinology 145:3265-3272
5. Di Fulvio M, Coleoni AH, Pellizas CG, Masini-Repiso AM 2000 Tri-iodothyronine induces proliferation in cultured bovine thyroid cells: evidence for the involvement of epidermal growth factor-associated tyrosine kinase activity. J Endocrinol 166:173-182
6. Malik R, Mellor N, Selden C, Hodgson H 2003 Triiodothyronine enhances the regenerative capacity of the liver following partial hepatectomy. Hepatology 37:79-86
7. Garcia-Silva S, Aranda A 2004 The thyroid hormone receptor is a suppressor of ras-mediated transcription, proliferation, and transformation. Mol Cell Biol 24:7514-7523
8. Ghosh M, Gharami K, Paul S, Das S 2005 Thyroid hormone-induced morphological differentiation and maturation of astrocytes involves activation of protein kinase A and ERK signalling pathway. Eur J Neurosci 22:1609-1617
9. Lee JW, Chen JY, Yang CS, Doong SL 2002 Thyroid hormone receptor α 1 (c-erb Aα1) suppressed transforming phenotype of nasopharyngeal carcinoma cell line. Cancer Lett 184:149-156
10. Yen CC, Huang YH, Liao CY, Liao CJ, Cheng WL, Chen WJ, Lin KH 2006 Mediation of the inhibitory effect of thyroid hormone on proliferation of hepatoma cells by transforming growth factor-β. J Mol Endocrinol 36:9-21
11. Hinkle PM, Kinsella PA 1986 Thyroid hormone induction of an autocrine growth factor secreted by pituitary tumor cells. Science 234:1549-1552
12. 1 cyclin/cyclin-dependent kinase levels and activity. Endocrinology 140:5267-5274
13. Sato H, Eby JE, Pakala R, Sirbasku DA 1992 Apotransferrins from several species promote thyroid hormonedependent rat pituitary tumor cell growth in iron-restricted serum-free defined culture. Mol Cell Endocrinol 83:239-251
14. Yehuda-Shnaidman E, Kalderon B, Bar-Tana J 2005 Modulation of mitochondrial transition pore components by thyroid hormone. Endocrinology 146:2462-2472
15. Aggarwal BB 2004 Nuclear factor-κB: the enemy within. Cancer Cell 6:203-208
16. Baldwin AS, Jr 1996 The NF-κ B and I κ B proteins: new discoveries and insights. Annu Rev Immunol 14:649-683
17. Karin M, Ben-Neriah Y 2000 Phosphorylation meets ubiquitination: the control of NF-κ B activity. Annu Rev Immunol 18:621-663
18. Viatour P, Merville MP, Bours V, Chariot A 2005 Phosphorylation of NF-κB and IκB proteins: implications in cancer and inflammation. Trends Biochem Sci 30:43-52
19. Baldwin Jr AS 2001 Series introduction: the transcription factor NF-κB and human disease. J Clin Invest 107:3-6
20. Karin M, Hunter T 1995 Transcriptional control by protein phosphorylation: signal transmission from the cell surface to the nucleus. Curr Biol 5:747-757
21. Kyriakis JM, Avruch J 2001 Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation. Physiol Rev 81:807-869
22. Roux PP, Blenis J 2004 ERK and p38 MAPK-activated protein kinases: a family of protein kinases with diverse biological functions. Microbiol Mol Biol Rev 68:320-344
23. Wada T, Penninger JM 2004 Mitogen-activated protein kinases in apoptosis regulation. Oncogene 23:2838-2849
24. Stanciu M, Wang Y, Kentor R, Burke N, Watkins S, Kress G, Reynolds I, Klann E, Angiolieri MR, Johnson JW, De-Franco DB 2000 Persistent activation of ERK contributes to glutamate-induced oxidative toxicity in a neuronal cell line and primary cortical neuron cultures. J Biol Chem 275:12200-12206
25. Tombes RM, Auer KL, Mikkelsen R, Valerie K, Wymann MP, Marshall CJ, McMahon M, Dent P 1998 The mitogen-activated protein (MAP) kinase cascade can either stimulate or inhibit DNA synthesis in primary cultures of rat hepatocytes depending upon whether its activation is acute/phasic or chronic. Biochem J 330:1451-1460
26. Kerr JM, Gordon DF, Woodmansee WW, Sarapura VD, Ridgway EC, Wood WM 2005 Growth arrest of thyrotropic tumors by thyroid hormone is correlated with novel changes in Wnt-10A. Mol Cell Endocrinol 238:57-67
27. Woodmansee WW, Kerr JM, Tucker EA, Mitchell JR, Haakinson DJ, Gordon DF, Ridgway EC, Wood WM 2006 The proliferative status of thyrotropes is dependent on modulation of specific cell cycle regulators by thyroid hormone. Endocrinology 147:272-282
28. An JJ, Cho SR, Jeong DW, Park KW, Ahn YS, Baik JH 2003 Anti-proliferative effects and cell death mediated by two isoforms of dopamine D2 receptors in pituitary tumor cells. Mol Cell Endocrinol 206:49-62
29. Fombonne J, Reix S, Rasolonjanahary R, Danty E, Thirion S, Laforge-Anglade G, Bosler O, Mehlen P, Enjalbert A, Krantic S 2004 Epidermal growth factor triggers an original, caspase-independent pituitary cell death with heterogeneous phenotype. Mol Biol Cell 15:4938-4948
30. Keyse SM 2000 Protein phosphatases and the regulation of mitogen-activated protein kinase signalling. Curr Opin Cell Biol 12:186-192
31. Li J, Gorospe M, Hutter D, Barnes J, Keyse SM, Liu Y 2001 Transcriptional induction of MKP-1 in response to stress is associated with histone H3 phosphorylationacetylation. Mol Cell Biol 21:8213-8224
32. Chen P, Li J, Barnes J, Kokkonen GC, Lee JC, Liu Y 2002 Restraint of proinflammatory cytokine biosynthesis by mitogen-activated protein kinase phosphatase-1 in lipopolysaccharide-stimulated macrophages. J Immunol 169:6408-6416
33. Wu JJ, Roth RJ, Anderson EJ, Hong EG, Lee MK, Choi CS, Neufer PD, Shulman GI, Kim JK, Bennett AM 2006 Mice lacking MAP kinase phosphatase-1 have enhanced MAP kinase activity and resistance to diet-induced obesity. Cell Metab 4:61-73
34. Salojin KV, Owusu IB, Millerchip KA, Potter M, Platt KA, Oravecz T 2006 Essential role of MAPK phosphatase-1 in the negative control of innate immune responses. J Immunol 176:1899-1907
35. Abraham SM, Lawrence T, Kleiman A, Warden P, Medghalchi M, Tuckermann J, Saklatvala J, Clark AR 2006 Antiinflammatory effects of dexamethasone are partly dependent on induction of dual specificity phosphatase 1. J Exp Med 203:1883-1889
36. Sakaue H, Ogawa W, Nakamura T, Mori T, Nakamura K, Kasuga M 2004 Role of MAPK phosphatase-1 (MKP-1) in adipocyte differentiation. J Biol Chem 279:39951-39957
37. Chattopadhyay S, Machado-Pinilla R, Manguan-Garcia C, Belda-Iniesta C, Moratilla C, Cejas P, Fresno-Vara JA, de Castro-Carpeno J, Casado E, Nistal M, Gonzalez-Baron M, Perona R 2006 MKP1/CL100 controls tumor growth and sensitivity to cisplatin in non-small-cell lung cancer. Oncogene 25:3335-3345
38. Wang Z, Xu J, Zhou JY, Liu Y, Wu GS 2006 Mitogen-activated protein kinase phosphatase-1 is required for cisplatin resistance. Cancer Res 66:8870-8877
39. Wu W, Pew T, Zou M, Pang D, Conzen SD 2005 Glucocorticoid receptor-induced MAPK phosphatase-1 (MPK-1) expression inhibits paclitaxel-associated MAPK activation and contributes to breast cancer cell survival. J Biol Chem 280:4117-4124
40. Zhou JY, Liu Y, Wu GS 2006 The role of mitogen-activated protein kinase phosphatase-1 in oxidative damage-induced cell death. Cancer Res 66:4888-4894
41. Kim GS, Choi YK, Song SS, Kim WK, Han BH 2005 MKP-1 contributes to oxidative stress-induced apoptosis via inactivation of ERK1/2 in SH-SY5Y cells. Biochem Biophys Res Commun 338:1732-1738
42. Wu ZL, O'Kane TM, Scott RW, Savage MJ, Bozyczko-Coyne D 2002 Protein tyrosine phosphatases are upregulated and participate in cell death induced by polyglutamine expansion. J Biol Chem 277:44208-44213
43. Horiuchi M, Akishita M, Dzau VJ 1998 Molecular and cellular mechanism of angiotensin II-mediated apoptosis. Endocr Res 24:307-314
44. Horsch K, de Wet H, Schuurmans MM, Allie-Reid F, Cato AC, Cunningham J, Burrin JM, Hough FS, Hulley PA 2007 Mitogen-activated protein kinase phosphatase 1/dual specificity phophatase 1 mediates glucocorticoid inhibition of osteoblast proliferation. Mol Endocrinol 21:2929-2940
45. Kennedy SG, Wagner AJ, Conzen SD, Jordan J, Bellacosa A, Tsichlis PN, Hay N 1997 The PI 3-kinase/Akt signaling pathway delivers an anti-apoptotic signal. Genes Dev 11:701-713
46. Brondello JM, Pouyssegur J, McKenzie FR 1999 Reduced MAP kinase phosphatase-1 degradation after p42/p44MAPK-dependent phosphorylation. Science 286:2514-2517
47. Xia Z, Dickens M, Raingeaud J, Davis RJ, Greenberg ME 1995 Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 270:1326-1331
48. Lasa M, Abraham SM, Boucheron C, Saklatvala J, Clark AR 2002 Dexamethasone causes sustained expression of mitogen-activated protein kinase (MAPK) phosphatase 1 and phosphatase-mediated inhibition of MAPK p38. Mol Cell Biol 22:7802-7811
49. Kassel O, Sancono A, Kratzschmar J, Kreft B, Stassen M, Cato AC 2001 Glucocorticoids inhibit MAP kinase via increased expression and decreased degradation of MKP-1. EMBO J 20:7108-7116
50. Engelbrecht Y, de Wet H, Horsch K, Langeveldt CR, Hough FS, Hulley PA 2003 Glucocorticoids induce rapid up-regulation of mitogen-activated protein kinase phosphatase-1 and dephosphorylation of extracellular signal-regulated kinase and impair proliferation in human and mouse osteoblast cell lines. Endocrinology 144:412-422
51. Lee HY, Sueoka N, Hong WK, Mangelsdorf DJ, Claret FX, Kurie JM 1999 All-trans-retinoic acid inhibits Jun N-terminal kinase by increasing dual-specificity phosphatase activity. Mol Cell Biol 19:1973-1980
52. Xu Q, Konta T, Furusu A, Nakayama K, Lucio-Cazana J, Fine LG, Kitamura M 2002 Transcriptional induction of mitogen-activated protein kinase phosphatase 1 by retinoids. Selective roles of nuclear receptors and contribution to the antiapoptotic effect. J Biol Chem 277:41693-41700
53. Palm-Leis A, Singh US, Herbelin BS, Olsovsky GD, Baker KM, Pan J 2004 Mitogen-activated protein kinases and mitogen-activated protein kinase phosphatases mediate the inhibitory effects of all-trans retinoic acid on the hypertrophic growth of cardiomyocytes. J Biol Chem 279:54905-54917
54. Krepinsky J, Ingram AJ, James L, Ly H, Thai K, Cattran DC, Miller JA, Scholey JW 2002 17β-Estradiol modulates mechanical strain-induced MAPK activation in mesangial cells. J Biol Chem 277:9387-9394
55. Brondello JM, Brunet A, Pouyssegur J, McKenzie FR 1997 The dual specificity mitogen-activated protein kinase phosphatase-1 and -2 are induced by the p42/ p44MAPK cascade. J Biol Chem 272:1368-1376
56. Nagaya T, Fujieda M, Otsuka G, Yang JP, Okamoto T, Seo H 2000 A potential role of activated NF-κ B in the pathogenesis of euthyroid sick syndrome. J Clin Invest 106:393-402
57. Caldenhoven E, Liden J, Wissink S, Van de Stolpe A, Raaijmakers J, Koenderman L, Okret S, Gustafsson JA, Van der Saag PT 1995 Negative cross-talk between RelA and the glucocorticoid receptor: a possible mechanism for the antiinflammatory action of glucocorticoids. Mol Endocrinol 9:401-412
58. De Bosscher K, Vanden Berghe W, Haegeman G 2003 The interplay between the glucocorticoid receptor and nuclear factor-κB or activator protein-1: molecular mechanisms for gene repression. Endocr Rev 24:488-522
59. Palvimo JJ, Reinikainen P, Ikonen T, Kallio PJ, Moilanen A, Janne OA 1996 Mutual transcriptional interference between RelA and androgen receptor. J Biol Chem 271:24151-24156
60. Kalkhoven E, Wissink S, van der Saag PT, van der Burg B 1996 Negative interaction between the RelA(p65) subunit of NF-κB and the progesterone receptor. J Biol Chem 271:6217-6224
61. Calleros L, Lasa M, Toro MJ, Chiloeches A 2006 Low cell cholesterol levels increase NFκB activity through a p38 MAPK-dependent mechanism. Cell Signal 18:2292-2301
62. Kalaitzidis D, Gilmore TD 2005 Transcription factor cross-talk: the estrogen receptor and NF-κB. Trends Endocrinol Metab 16:46-52
63. Olivier S, Close P, Castermans E, de Leval L, Tabruyn S, Chariot A, Malaise M, Merville MP, Bours V, Franchimont N 2006 Raloxifene-induced myeloma cell apoptosis: a study of nuclear factor-κB inhibition and gene expression signature. Mol Pharmacol 69:1615-1623
64. Kosaka Y, Calderhead DM, Manning EM, Hambor JE, Black A, Geleziunas R, Marcu KB, Noelle RJ 1999 Activation and regulation of the IκB kinase in human B cells by CD40 signaling. Eur J Immunol 29:1353-1362
65. Zhong H, May MJ, Jimi E, Ghosh S 2002 The phosphorylation status of nuclear NF-κ B determines its association with CBP/p300 or HDAC-1. Mol Cell 9:625-636
66. Ashburner BP, Westerheide SD, Baldwin Jr AS 2001 The p65 (RelA) subunit of NF-κB interacts with the histone deacetylase (HDAC) corepressors HDAC1 and HDAC2 to negatively regulate gene expression. Mol Cell Biol 21:7065-7077
67. Yano O, Kanellopoulos J, Kieran M, Le Bail O, Israel A, Kourilsky P 1987 Purification of KBF1, a common factor binding to both H-2 and β2-microglobulin enhancers. EMBO J 6:3317-3324
68. Schmitz ML, Baeuerle PA 1991 The p65 subunit is responsible for the strong transcription activating potential of NF-κB. EMBO J 10:3805-3817
69. Perona R, Montaner S, Saniger L, Sanchez-Perez I, Bravo R, Lacal JC 1997 Activation of the nuclear factor-κB by Rho, CDC42, and Rac-1 proteins. Genes Dev 11:463-475
70. Flug F, Copp RP, Casanova J, Horowitz ZD, Janocko L, Plotnick M, Samuels HH 1987 cis-Acting elements of the rat growth hormone gene which mediate basal and regulated expression by thyroid hormone. J Biol Chem 262:6373-6382
71. Yano S, Ghosh P, Kusaba H, Buchholz M, Longo DL 2003 Effect of promoter methylation on the regulation of IFN-γ gene during in vitro differentiation of human peripheral blood T cells into a Th2 population. J Immunol 171:2510-2516